Muniandy M, Heinonen S, Yki-Järvinen H, Hakkarainen A, Lundbom J, Lundbom N, Kaprio J, Rissanen A, Ollikainen M, Pietiläinen K H
Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
Obesity Research Unit, Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki, Finland.
Int J Obes (Lond). 2017 Aug;41(8):1176-1184. doi: 10.1038/ijo.2017.95. Epub 2017 Apr 25.
Subcutaneous adipose tissue (SAT) undergoes major changes in obesity, but little is known about the whole-genome scale patterns of these changes or about their variation between different obesity sub-groups. We sought to compare how transcriptomics profiles in SAT differ between monozygotic (MZ) co-twins who are discordant for body mass index (BMI), whether the profiles vary between twin pairs and whether the variation can be linked to clinical characteristics.
We analysed the transcriptomics (Affymetrix U133 Plus 2.0) patterns of SAT in young MZ twin pairs (n=26, intra-pair difference in BMI >3 kg m, aged 23-36), from 10 birth cohorts of adult Finnish twins. The clinical data included measurements of body composition, insulin resistance, lipids and adipokines.
We found 2108 genes differentially expressed (false discovery rate (FDR)<0.05) in SAT of the BMI-discordant pairs. Pathway analyses of these genes revealed a significant downregulation of mitochondrial oxidative pathways (P<0.05) and upregulation of inflammation pathways (P<0.05). Hierarchical clustering of heavy/lean twin ratios, representing effects of acquired obesity in the transcriptomics data, revealed three sub-groups with different molecular profiles (FDR<0.05). Analyses comparing these sub-groups showed that, in the heavy co-twins, downregulation of the mitochondrial pathways, especially that of branched chain amino acid degradation was more evident in two clusters while and upregulation of the inflammatory response was most evident in the last, presumably the unhealthiest cluster. High-fasting insulin levels and large adipocyte diameter were the predominant clinical characteristic of the heavy co-twins in this cluster (Bonferroni-adjusted P<0.05).
This is the first study in BMI-discordant MZ twin pairs reporting sub-types of obesity based on both SAT gene expression profiles and clinical traits. We conclude that a decrease in mitochondrial BCAA degradation and an increase in inflammation in SAT co-occur and associate with hyperinsulinemia and large adipocyte size in unhealthy obesity.
皮下脂肪组织(SAT)在肥胖过程中会发生重大变化,但对于这些变化的全基因组规模模式或不同肥胖亚组之间的差异知之甚少。我们试图比较体重指数(BMI)不一致的同卵(MZ)双胞胎对中SAT的转录组学谱有何不同,这些谱在双胞胎对之间是否存在差异,以及这种差异是否与临床特征相关。
我们分析了来自10个芬兰成年双胞胎出生队列的年轻MZ双胞胎对(n = 26,双胞胎对之间的BMI差异>3 kg/m²,年龄23 - 36岁)的SAT转录组学(Affymetrix U133 Plus 2.0)模式。临床数据包括身体成分、胰岛素抵抗、血脂和脂肪因子的测量。
我们发现BMI不一致的双胞胎对的SAT中有2108个基因差异表达(错误发现率(FDR)<0.05)。对这些基因的通路分析显示线粒体氧化通路显著下调(P<0.05),炎症通路上调(P<0.05)。代表转录组学数据中后天性肥胖影响的重/瘦双胞胎比率的层次聚类揭示了三个具有不同分子谱的亚组(FDR<0.05)。对这些亚组的分析表明,在较重的双胞胎中,线粒体通路的下调,尤其是支链氨基酸降解通路的下调在两个聚类中更为明显,而炎症反应的上调在最后一个聚类中最为明显,推测这是最不健康的聚类。高空腹胰岛素水平和大脂肪细胞直径是该聚类中较重双胞胎的主要临床特征(Bonferroni校正P<0.05)。
这是第一项在BMI不一致的MZ双胞胎对中基于SAT基因表达谱和临床特征报告肥胖亚型的研究。我们得出结论,SAT中线粒体支链氨基酸降解减少和炎症增加同时发生,并与不健康肥胖中的高胰岛素血症和大脂肪细胞大小相关。